According to previous reports, Tollip limits the production of pro-inflammatory mediators during inflammation and infection [30], and not only has been implicated as a negative regulator of the NF-κB signaling pathway but also controls the magnitude of inflammatory cytokine production in response to LPS [10]. The gene discussed is NFKB1; the disease is infection.